Document is current
Any future updates will be listed below
-
Authors
Danve, Abhijeet
Deodhar, Atul http://orcid.org/0000-0002-2130-1246
- License Information
-
More Information
Article History
Accepted: 3 February 2022
First Online: 10 March 2022
Competing interests
: A. Danve: research grants from Novartis, Lilly; advisory boards at Janssen, AbbVie and Amgen; member of the Spondyloarthritis Research and Treatment Network and the Assessment of Spondyloarthritis International Society. A. Deodhar: research grants from AbbVie, Celgene, Eli Lilly, Glaxo Smith Kline, Novartis, Pfizer and UCB; advisory boards and consulting at AbbVie, Amgen, Aurinia, Bristol Myers Squibb, Celgene, Eli Lilly, Glaxo Smith Kline, Janssen, MoonLake, Novartis, Pfizer and UCB; member of the Spondyloarthritis Research and Treatment Network, the Assessment of Spondyloarthritis International Society and the Scientific Advisory Board of Spondylitis Association of America.
